Table 3

Cox proportional hazard model to test the significance of clinical covariates and genotypes of the CYP11B2 polymorphism as predictors of renal survival

Variablep valueHR95% CI
HR, hazard ratio; CI, confidence interval; ACEI/ARB, angiotensin-I converting enzyme inhibitor and/or angiotensin receptor blocker.
Urinary protein excretion >1.0 g/day<0.00013.3621.891 to 5.977
Hypertension0.00072.3011.423 to 3.721
No ACEI/ARB administration0.00022.7791.629 to 4.740
CC genotype of CYP11B20.16671.5840.825 to 3.042